BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30570758)

  • 1. YAPping about and not forgetting TAZ.
    Callus BA; Finch-Edmondson ML; Fletcher S; Wilton SD
    FEBS Lett; 2019 Feb; 593(3):253-276. PubMed ID: 30570758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of Hippo-YAP/TAZ signaling pathway in mechanotransduction.].
    Ishihara E; Nishina H
    Clin Calcium; 2016; 26(12):1751-1756. PubMed ID: 27885187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
    Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
    J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment.
    Santucci M; Vignudelli T; Ferrari S; Mor M; Scalvini L; Bolognesi ML; Uliassi E; Costi MP
    J Med Chem; 2015 Jun; 58(12):4857-73. PubMed ID: 25719868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippo-YAP/TAZ signalling in organ regeneration and regenerative medicine.
    Moya IM; Halder G
    Nat Rev Mol Cell Biol; 2019 Apr; 20(4):211-226. PubMed ID: 30546055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Real-Time PCR to Measure YAP/TAZ Activity in Human Cells.
    Cao X; Zhao B
    Methods Mol Biol; 2019; 1893():137-152. PubMed ID: 30565132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA binding partners of YAP/TAZ.
    Kim MK; Jang JW; Bae SC
    BMB Rep; 2018 Mar; 51(3):126-133. PubMed ID: 29366442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hippo-YAP/TAZ signaling in angiogenesis.
    Park JA; Kwon YG
    BMB Rep; 2018 Mar; 51(3):157-162. PubMed ID: 29366443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.
    Noto A; De Vitis C; Pisanu ME; Roscilli G; Ricci G; Catizone A; Sorrentino G; Chianese G; Taglialatela-Scafati O; Trisciuoglio D; Del Bufalo D; Di Martile M; Di Napoli A; Ruco L; Costantini S; Jakopin Z; Budillon A; Melino G; Del Sal G; Ciliberto G; Mancini R
    Oncogene; 2017 Aug; 36(32):4573-4584. PubMed ID: 28368399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Context-dependent transcriptional regulations of YAP/TAZ in stem cell and differentiation.
    Luo J; Li P
    Stem Cell Res Ther; 2022 Jan; 13(1):10. PubMed ID: 35012640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of YAP/TAZ Activity by Mechanical Cues: An Experimental Overview.
    Dupont S
    Methods Mol Biol; 2019; 1893():183-202. PubMed ID: 30565135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hippo Pathway: An Emerging Regulator of Craniofacial and Dental Development.
    Wang J; Martin JF
    J Dent Res; 2017 Oct; 96(11):1229-1237. PubMed ID: 28700256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YAP/TAZ for cancer therapy: opportunities and challenges (review).
    Guo L; Teng L
    Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the Hippo Pathway Transcription Factor TEAD.
    Lin KC; Park HW; Guan KL
    Trends Biochem Sci; 2017 Nov; 42(11):862-872. PubMed ID: 28964625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippo pathway - brief overview of its relevance in cancer.
    Zygulska AL; Krzemieniecki K; Pierzchalski P
    J Physiol Pharmacol; 2017 Jun; 68(3):311-335. PubMed ID: 28820389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hippo Signaling Pathway in Pancreatic Cancer.
    Ansari D; Ohlsson H; Althini C; Bauden M; Zhou Q; Hu D; Andersson R
    Anticancer Res; 2019 Jul; 39(7):3317-3321. PubMed ID: 31262852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippo signalling in the liver: role in development, regeneration and disease.
    Russell JO; Camargo FD
    Nat Rev Gastroenterol Hepatol; 2022 May; 19(5):297-312. PubMed ID: 35064256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease.
    Varelas X
    Development; 2014 Apr; 141(8):1614-26. PubMed ID: 24715453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of YAP and TAZ in Angiogenesis and Vascular Mimicry.
    Azad T; Ghahremani M; Yang X
    Cells; 2019 May; 8(5):. PubMed ID: 31052445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates ΔNp63 Transcription through TEA Domain (TEAD) Transcription Factor.
    Valencia-Sama I; Zhao Y; Lai D; Janse van Rensburg HJ; Hao Y; Yang X
    J Biol Chem; 2015 Jul; 290(27):16906-17. PubMed ID: 25995450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.